Combined effect of Neridronate and specific antibiotic therapy in a case of tuberculous spondylodiscitis

被引:3
作者
Quarta, L. [2 ]
Corrado, A. [2 ]
Melillo, N. [2 ]
Trotta, A. [2 ]
Scotto, G. [3 ]
d'Onofrio, F. [2 ]
Santoro, N. [2 ]
Cantatore, F. P. [1 ,2 ]
机构
[1] Davanzo Hosp, Rheumatol Clin Mario Carrozzo, I-71100 Foggia, Italy
[2] Univ Foggia, Sch Med, Dept Rheumatol, Foggia, Italy
[3] Riuniti Hosp, Dept Infect Dis, Foggia, Italy
关键词
tuberculous spondylodiscitis; Neridronate; chemotherapy;
D O I
10.1007/s00296-007-0460-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Because of the increased incidence of tuberculosis (TB) in recent years, infective spondylitis is still a major problem in the world. In skeletal TB the spine is the most often involved and lumbosacral spine involvement is rare. Nowadays early diagnosis and new medical treatment can reduce the incidence of the serious skeletal sequelae and the number of surgery procedures in spinal TB. We present a case of TB spondylodiscitis characterized by a rapid and progressive clinical and radiological improvement after treatment with Neridronate and chemotherapic drugs. Our data suggest that in the treatment of the TB spondylodiscitis the combined use of these drugs is a good alternative to stimulate bone reparative process to the chemotherapy alone. To our knowledge this is first case of a patient with TB discitis treated with Neridronate. Further studies are necessary to confirm the effectiveness of Neridronate treatment added to antiTB drugs in spondylodiscitis.
引用
收藏
页码:495 / 498
页数:4
相关论文
共 14 条
  • [1] ABHAY N, 2005, SPINE, V5, P79
  • [2] *CDC, 2003, MMWR-MORBID MORTAL W, V52, P15
  • [3] Long-term effects of neridronate on human osteoblastic cell cultures
    Frediani, B
    Spreafico, A
    Capperucci, C
    Chellini, F
    Gambera, D
    Ferrata, P
    Baldi, F
    Falsetti, P
    Santucci, A
    Bocchi, L
    Marcolongo, R
    [J]. BONE, 2004, 35 (04) : 859 - 869
  • [4] Activity of moxifloxacin against mycobacteria
    Gillespie, SH
    Billington, O
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (03) : 393 - 395
  • [5] A comparison of the bactericidal activity of quinolone antibiotics in a Mycobacterium fortuitum model
    Gillespie, SH
    Morrissey, I
    Everett, D
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 2001, 50 (06) : 565 - 570
  • [6] Golden MP, 2005, AM FAM PHYSICIAN, V72, P1761
  • [7] GROSSKOPF I, 1994, ISRAEL J MED SCI, V30, P278
  • [8] IN-VITRO AND IN-VIVO ACTIVITIES OF LEVOFLOXACIN AGAINST MYCOBACTERIUM-TUBERCULOSIS
    JI, BH
    LOUNIS, N
    TRUFFOTPERNOT, C
    GROSSET, J
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) : 1341 - 1344
  • [9] Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis
    Kennedy, N
    Berger, L
    Curram, J
    Fox, R
    Gutmann, J
    Kisyombe, GM
    Ngowi, FI
    Ramsay, ARC
    Saruni, AOS
    Sam, N
    Tillotson, G
    Uiso, LO
    Yates, M
    Gillespie, SH
    [J]. CLINICAL INFECTIOUS DISEASES, 1996, 22 (05) : 827 - 833
  • [10] DIPHOSPHONATES INHIBIT HUMAN OSTEOBLAST SECRETION AND PROLIFERATION
    KHOKHER, MA
    DANDONA, P
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1989, 38 (02): : 184 - 187